Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Automated eligibility screening and monitoring for genotype-driven precision oncology trials.

Journal of the American Medical Informatics Association : JAMIA - 1 Jul 2016

Eubank Michael H, Hyman David M, Kanakamedala Amritha D, Gardos Stuart M, Wills Jonathan M, Stetson Peter D

Abstract excerpt

The Information Systems Department at Memorial Sloan Kettering Cancer Center developed the DARWIN Cohort Management System (DCMS). The DCMS identifies and tracks cohorts of patients based on genotypic and clinical data. It assists researchers and treating physicians in enrolling patients to genotype-matched IRB-approved clinical trials. The DCMS sends automated, actionable, and secure email notifications to users...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Databases, Factual

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Information Systems

Share to Medical Oncology

Share to New York City

Share to Patient Selection

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 27016727
DOI: 10.1093/jamia/ocw020
PMCID: PMC6370254

Genes

IMPACT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Automated eligibility screening and monitoring for genotype-driven precision oncology trials.PMID 27016727Read ↗

A Precision Oncology Platform to Support Genotype-Tailored Therapy Selection.Semantic proximity Read ↗

MatchMiner: An open source platform for cancer precision medicineSemantic proximity Read ↗

Implementation of a Molecular Tumor Registry to Support the Adoption of Precision Oncology Within an Academic Medical Center: The Duke University ExperienceSemantic proximity Read ↗

MatchMiner: An open source computational platform for real-time matching of cancer patients to precision medicine clinical trials using genomic and clinical criteriaSemantic proximity Read ↗

Clinical genomics information management software linking cancer genome sequence and clinical decisions.Semantic proximity Read ↗

OncoCTMiner: streamlining precision oncology trial matching via molecular profile analysisSemantic proximity Read ↗

AstraKit: Customizable, reproducible workflows for biomedical research and precision medicineSemantic proximity Read ↗

The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies.Semantic proximity Read ↗

Clinical Use of Precision Oncology Decision SupportSemantic proximity Read ↗

Precision oncology: lessons learned and challenges for the futureSemantic proximity Read ↗

CancerStop.dev: An Interactive Web Platform Integrating Prognostic Data, Clinical Trials, and Genomic Resources for Patient EmpowermentSemantic proximity Read ↗

Implementing a data infrastructure for precision oncology projects leveraging REDCapSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.